Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CAPD in a large population: a 7-year experience.

F Quarello1, F Bonello, R Boero

  • 1Nephro-Urology Institute, University of Torino, Italy.

Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|January 1, 1989
PubMed
Summary

Continuous ambulatory peritoneal dialysis (CAPD) is a viable treatment for chronic uremia, showing comparable survival rates to hemodialysis. However, high dropout rates due to peritonitis and other complications remain a challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pola-R-CHP for frontline therapy in DLBCL: Are we saving money by spending more?

British journal of haematology·2023
Same author

Effects of supplementation of sea buckthorn press cake on mycelium growth and polysaccharides of Inonotus obliquus in submerged cultivation.

Journal of applied microbiology·2021
Same author

Effect of malolactic fermentation by Pediococcus damnosus on the composition and sensory profile of Albariño and Caiño white wines.

Journal of applied microbiology·2013
Same author

[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2013
Same author

[How to start dialysis. Peritoneal dialysis--clinical aspects].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2008
Same author

Role of fosfomycin tromethamine in modulating non-specific defence mechanisms in chronic uremic patients towards ESBL-producing Escherichia coli.

International journal of immunopathology and pharmacology·2008

Area of Science:

  • Nephrology
  • Epidemiology
  • Renal Replacement Therapy

Background:

  • Chronic uremia management involves various dialysis modalities.
  • Continuous ambulatory peritoneal dialysis (CAPD) is one such treatment option.
  • Understanding its long-term outcomes and challenges is crucial for patient care.

Purpose of the Study:

  • To evaluate the outcomes of CAPD in uremic patients in Piedmont, Italy over a 7-year period.
  • To assess the diffusion, patient demographics, and complication rates associated with CAPD.
  • To compare CAPD survival rates with hemodialysis.

Main Methods:

  • Data collected from a regional dialysis and transplantation registry (7-year period).
  • Analysis of 3,567 patients, with a focus on 193 patients on CAPD.

Related Experiment Videos

  • Epidemiological survey including survival analysis and dropout reasons.

    • Main Results:

    • CAPD use was relatively constant (11%) but varied significantly across centers.
    • CAPD was frequently used in elderly patients and a first choice for diabetics.
    • High dropout rates (66%) were observed, with peritonitis being the primary cause (22%).
    • No significant difference in survival rates between CAPD and hemodialysis across age groups.

    Conclusions:

    • CAPD is a competitive treatment option for chronic uremia.
    • Strategies to mitigate high dropout rates, particularly peritonitis, are needed.
    • CAPD demonstrates comparable long-term survival to hemodialysis, especially in specific patient groups.